Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric Immune Thrombocytopenia

Taylor Olmsted Kim,Jennifer M Geris Dr,Jonathan Michael Flanagan,Rachael F Grace,Michele P Lambert,Candelaria O'Farrell,Melissa J Rose,Kristin A Shimano,Omar Niss,Cindy E Neunert,Taizo A Nakano,Derek MacMath,Bogdan Dinu,Susan E Kirk,Ellis J Neufeld,Jenny McDade Despotovic,Michael E Scheurer,Amanda B Grimes
DOI: https://doi.org/10.1182/bloodadvances.2024012776
2024-08-27
Abstract:Through the use of genetic sequencing, molecular variants driving autoimmunity are increasingly identified in patients with chronic and refractory immune cytopenias. With the goal of discovering genetic variants that predispose to pediatric immune thrombocytopenia (ITP) or increase risk for chronic disease, we conducted a genome-wide association study in a large multi-institutional cohort of pediatric patients with ITP. Five-hundred ninety-one patients were genotyped using an Illumina Global Screening Array (GSA) BeadChip. Six variants met genome wide significance in comparison between children with ITP and a cohort of healthy children. One variant in NAV2 was inversely associated with ITP (aOR: 0.52, P=3.2x10-11). Two other variants in close proximity to NKD1 were also inversely associated with ITP (aOR: 0.43, P=8.86x10-15; aOR: 0.48, P=1.84x10-16). These genes have been linked to the canonical Wnt signaling pathway. No variants met genome-wide significance in comparison of those with ITP that self-resolved in less than 1 year versus those who developed chronic ITP. This study identifies genetic variants which may contribute to ITP risk and raises a novel pathway with a potential role in ITP pathogenesis.
What problem does this paper attempt to address?